Review



anti dkk3 biotinylated polyclonal goat antibody  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    R&D Systems anti dkk3 biotinylated polyclonal goat antibody
    <t>DKK3</t> cleavage utilization as PD biomarker in the phase 1 study following treatment with anti-HtrA1 Fab15H6.v4.D221. The SAD stage consisted of doses of anti-HtrA1 Fab15H6.v4.D221 ranging from 1 to 20 mg ( n = 15). Levels of cleaved DKK3 were assessed by Western blot in aqueous humor of patients at baseline and at multiple time points following anti-HtrA1 treatment as a biomarker of anti-HtrA1 modulation of HtrA1 protease activity. A plot of percent change from baseline for aqueous humor cleaved DKK3 by study day is shown for each treatment group.
    Anti Dkk3 Biotinylated Polyclonal Goat Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+dkk3+biotinylated+polyclonal+goat+antibody/pmc07211935-233-4-9?v=R%26D+Systems
    Average 90 stars, based on 3 article reviews
    anti dkk3 biotinylated polyclonal goat antibody - by Bioz Stars, 2026-07
    90/100 stars

    Images

    1) Product Images from "Development of a therapeutic anti-HtrA1 antibody and the identification of DKK3 as a pharmacodynamic biomarker in geographic atrophy"

    Article Title: Development of a therapeutic anti-HtrA1 antibody and the identification of DKK3 as a pharmacodynamic biomarker in geographic atrophy

    Journal: Proceedings of the National Academy of Sciences of the United States of America

    doi: 10.1073/pnas.1917608117

    DKK3 cleavage utilization as PD biomarker in the phase 1 study following treatment with anti-HtrA1 Fab15H6.v4.D221. The SAD stage consisted of doses of anti-HtrA1 Fab15H6.v4.D221 ranging from 1 to 20 mg ( n = 15). Levels of cleaved DKK3 were assessed by Western blot in aqueous humor of patients at baseline and at multiple time points following anti-HtrA1 treatment as a biomarker of anti-HtrA1 modulation of HtrA1 protease activity. A plot of percent change from baseline for aqueous humor cleaved DKK3 by study day is shown for each treatment group.
    Figure Legend Snippet: DKK3 cleavage utilization as PD biomarker in the phase 1 study following treatment with anti-HtrA1 Fab15H6.v4.D221. The SAD stage consisted of doses of anti-HtrA1 Fab15H6.v4.D221 ranging from 1 to 20 mg ( n = 15). Levels of cleaved DKK3 were assessed by Western blot in aqueous humor of patients at baseline and at multiple time points following anti-HtrA1 treatment as a biomarker of anti-HtrA1 modulation of HtrA1 protease activity. A plot of percent change from baseline for aqueous humor cleaved DKK3 by study day is shown for each treatment group.

    Techniques Used: Biomarker Discovery, Western Blot, Activity Assay



    Similar Products

    anti dkk3 biotinylated polyclonal goat antibody  (R&D Systems)
    90
    R&D Systems anti dkk3 biotinylated polyclonal goat antibody
    <t>DKK3</t> cleavage utilization as PD biomarker in the phase 1 study following treatment with anti-HtrA1 Fab15H6.v4.D221. The SAD stage consisted of doses of anti-HtrA1 Fab15H6.v4.D221 ranging from 1 to 20 mg ( n = 15). Levels of cleaved DKK3 were assessed by Western blot in aqueous humor of patients at baseline and at multiple time points following anti-HtrA1 treatment as a biomarker of anti-HtrA1 modulation of HtrA1 protease activity. A plot of percent change from baseline for aqueous humor cleaved DKK3 by study day is shown for each treatment group.
    Anti Dkk3 Biotinylated Polyclonal Goat Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+dkk3+biotinylated+polyclonal+goat+antibody/pmc07211935-233-4-9?v=R%26D+Systems
    Average 90 stars, based on 1 article reviews
    anti dkk3 biotinylated polyclonal goat antibody - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    goat polyclonal anti dkk3  (R&D Systems)
    90
    R&D Systems goat polyclonal anti dkk3
    <t>DKK3</t> cleavage utilization as PD biomarker in the phase 1 study following treatment with anti-HtrA1 Fab15H6.v4.D221. The SAD stage consisted of doses of anti-HtrA1 Fab15H6.v4.D221 ranging from 1 to 20 mg ( n = 15). Levels of cleaved DKK3 were assessed by Western blot in aqueous humor of patients at baseline and at multiple time points following anti-HtrA1 treatment as a biomarker of anti-HtrA1 modulation of HtrA1 protease activity. A plot of percent change from baseline for aqueous humor cleaved DKK3 by study day is shown for each treatment group.
    Goat Polyclonal Anti Dkk3, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+dkk3+biotinylated+polyclonal+goat+antibody/pmc06143799-81-18-21?v=R%26D+Systems
    Average 90 stars, based on 1 article reviews
    goat polyclonal anti dkk3 - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    DKK3 cleavage utilization as PD biomarker in the phase 1 study following treatment with anti-HtrA1 Fab15H6.v4.D221. The SAD stage consisted of doses of anti-HtrA1 Fab15H6.v4.D221 ranging from 1 to 20 mg ( n = 15). Levels of cleaved DKK3 were assessed by Western blot in aqueous humor of patients at baseline and at multiple time points following anti-HtrA1 treatment as a biomarker of anti-HtrA1 modulation of HtrA1 protease activity. A plot of percent change from baseline for aqueous humor cleaved DKK3 by study day is shown for each treatment group.

    Journal: Proceedings of the National Academy of Sciences of the United States of America

    Article Title: Development of a therapeutic anti-HtrA1 antibody and the identification of DKK3 as a pharmacodynamic biomarker in geographic atrophy

    doi: 10.1073/pnas.1917608117

    Figure Lengend Snippet: DKK3 cleavage utilization as PD biomarker in the phase 1 study following treatment with anti-HtrA1 Fab15H6.v4.D221. The SAD stage consisted of doses of anti-HtrA1 Fab15H6.v4.D221 ranging from 1 to 20 mg ( n = 15). Levels of cleaved DKK3 were assessed by Western blot in aqueous humor of patients at baseline and at multiple time points following anti-HtrA1 treatment as a biomarker of anti-HtrA1 modulation of HtrA1 protease activity. A plot of percent change from baseline for aqueous humor cleaved DKK3 by study day is shown for each treatment group.

    Article Snippet: Primary antibodies used include anti-DKK3 biotinylated polyclonal goat antibody (R&D Systems; BAF1118), anti-RBP3 rabbit polyclonal antibody (Proteintech; 14352-1-AP), anti-HtrA1:7816 19G10 mouse IgG2a monoclonal antibody (Genentech), and human CLU biotinylated goat polyclonal antibody (R&D Systems; BAF2937).

    Techniques: Biomarker Discovery, Western Blot, Activity Assay